MR. JEFFREY MICHAEL THOMAS, P.A.
Physician Assistant at Hawthorne Ave, Oakland, CA
License number
California PA18396
Category
Nursing
Type
Physician Assistant
Address
Address
2
350 Hawthorne Ave, Oakland, CA 94609
PO Box 12469, Westminster, CA 92685
PO Box 12469, Westminster, CA 92685
Phone
(866) 325-0282
Personal information
See more information about JEFFREY MICHAEL THOMAS at radaris.comName
Address
Phone
5015 West Blvd, Los Angeles, CA 90043
4 Bentley Ave, Sacramento, CA 95823
4 Tamarac Pl, Aliso Viejo, CA 92656
5001 Morrill Ct, El Dorado Hls, CA 95762
520 Fairway Dr, Ione, CA 95640
Professional information
Jeffrey M Thomas, Oakland CA - PA (Physician assistant; also Posterior–anterior)
Specialties:
Physician Assistant (PA)
Address:
350 Hawthorne Ave, Oakland 94609
(866) 325-0282 (Phone)
(866) 325-0282 (Phone)
Languages:
English
Hospitals:
350 Hawthorne Ave, Oakland 94609
Alta Bates Summit Medical Center - Summit
350 Hawthorne Ave, Oakland 94609
Alta Bates Summit Medical Center - Summit
350 Hawthorne Ave, Oakland 94609
Methods And Nucleic Acids For The Analysis Of Gene Expression Associated With The Prognosis Of Prostate Cell Proliferative Disorders
US Patent:
2009019, Aug 6, 2009
Filed:
Dec 2, 2005
Appl. No.:
11/720744
Inventors:
Susan Cottrell - Seattle WA, US
Fabian Model - Berlin, DE
Carolina Haefliger - Basel, CH
Gunter Weiss - Berlin, DE
Juergen Distler - Berlin, DE
Andrew Z. Sledziewski - Shoreline WA, US
Xiaoling Song - Woodinville WA, US
Thomas L. Skillman - Kennydale WA, US
Jeffrey G. Thomas - Emeryville CA, US
Fabian Model - Berlin, DE
Carolina Haefliger - Basel, CH
Gunter Weiss - Berlin, DE
Juergen Distler - Berlin, DE
Andrew Z. Sledziewski - Shoreline WA, US
Xiaoling Song - Woodinville WA, US
Thomas L. Skillman - Kennydale WA, US
Jeffrey G. Thomas - Emeryville CA, US
Assignee:
EPIGENOMICS AG - Berlin DE
International Classification:
C12Q 1/68, G01N 1/30, C40B 30/04, C07H 21/04
US Classification:
435 6, 435 4052, 506 9, 536 235
Abstract:
Particular aspects provide novel methods and compositions (e.g., nucleic acids, kits, etc.) having substantial utility for providing a prognosis of prostate cell proliferative disorders. In particular aspects, this is achieved by the analysis of the expression status of a panel of genes, or subsets thereof.